Nutranomics (NNRX) 10-Q 15 Jul 15 2015 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Apr. 30, 2015	Jul. 10, 2015
Document And Entity Information [Abstract]
Entity Registrant Name	NUTRANOMICS, INC.
Entity Central Index Key	1,451,433
Trading Symbol	nnrx
Current Fiscal Year End Date	--07-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		169,538,137
Document Type	10-Q
Document Period End Date	Apr. 30, 2015
Amendment Flag	false
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Apr. 30, 2015	Jul. 31, 2014
CURRENT ASSETS
Cash and cash equivalents	$ 39,273	$ 79,235
Accounts receivable, net of allowance	151,810	152,879
Prepaid expenses	1,283	4,516
Other current assets	49,313	23,254
Inventory	136,542	271,941
Total Current Assets	378,221	531,825
PROPERTY & EQUIPMENT, net	10,583	16,355
INTANGIBLES, net	44,833
OTHER ASSETS
Rent deposit	2,000	2,000
Total Assets	435,637	550,180
CURRENT LIABILITIES
Accounts payable and accrued expenses	494,411	518,890
Lines of credit	36,234	33,098
Convertible notes payable-current portion net of discount	467,560	58,999
Loan payable-current portion	35,426	51,071
Note Derivative Liability	188,391	177,907
Warrant Liability	115,782
Related party payable	17,239	21,083
Related party notes payable		36,608
Unearned revenue	315,327	338,263
Total Current Liabilities	1,670,370	1,235,919
LONG-TERM LIABILITIES
Convertible notes payable	181,426	525,000
Loan payable	142,190	157,830
Total Liabilities	1,993,986	1,918,749
STOCKHOLDERS' DEFICIT
Common stock; par value of $.001, 750,000,000 shares authorized; 161,481,887 and 51,151,766 shares issued and outstanding at April 30, 2015 and July 31, 2014, respectively	161,482	51,153
Additional paid in capital	4,159,137	3,337,911
Accumulated deficit	(5,878,855)	(4,757,633)
Accumulated Other Comprehensive Income	(113)
Total Stockholders' Deficit	(1,558,349)	(1,368,569)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT	$ 435,637	$ 550,180

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - $ / shares	Apr. 30, 2015	Jul. 31, 2014
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares authorized	750,000,000	750,000,000
Common stock, shares issued	161,481,887	51,151,766
Common stock, shares outstanding	161,481,887	51,151,766

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014
Income Statement [Abstract]
REVENUES	$ 432,414	$ 716,763	$ 1,345,110	$ 1,943,742
COST OF SALES	197,052	370,129	659,379	1,269,526
GROSS PROFIT	235,362	346,634	685,731	674,216
OPERATING EXPENSES
General and administrative	86,661	161,951	265,704	402,048
Professional fees	111,939	338,197	310,337	930,350
Research and development		616	93	32,233
Salaries and wages	139,928	146,780	931,499	760,886
Total Operating Expenses	338,528	647,544	1,507,633	2,125,517
OPERATING (LOSS)	(103,166)	(300,910)	(821,902)	(1,451,301)
OTHER INCOME (EXPENSE)
Other income	999		999
Loss on settlement of fraudulent activity				(37,300)
Change in Fair Value of Derivative	33,305	5,981	49,878	6,598
Interest expense	(69,197)	(32,425)	(350,197)	(71,326)
Total Other Income (Expense)	(34,893)	(26,444)	(299,320)	(102,028)
NET (LOSS) BEFORE INCOME TAXES	$ (138,059)	$ (327,354)	$ (1,121,222)	$ (1,553,329)
Provision for income taxes
NET (LOSS)	$ (138,059)	$ (327,354)	$ (1,121,222)	$ (1,553,329)
BASIC AND DILUTED LOSS PER SHARE (in dollars per share)	$ 0	$ (0.01)	$ (0.01)	$ (0.03)
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING (in shares)	152,764,167	49,180,788	89,138,400	47,446,714
NET INCOME (LOSS)	$ (138,059)	$ (327,354)	$ (1,121,222)	$ (1,553,329)
Foreign Currency Translation	(5)		(113)
TOTAL COMPREHENSIVE INCOME (LOSS)	$ (138,064)	$ (327,354)	$ (1,121,335)	$ (1,553,329)

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit - USD ($)	Common Stock	Additional Paid in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balance at Jul. 31, 2013	$ 25,006	$ 2,271,519	$ (2,585,391)		$ (288,866)
Balance (in shares) at Jul. 31, 2013	25,005,544
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for merger	$ 21,500	(20,100)			1,400
Common stock issued for merger (in shares)	21,500,000
Common stock issued for cash	$ 1,500	91,912			93,412
Common stock issued for cash (in shares)	1,500,000
Common stock issued for services	$ 2,430	805,422			807,852
Common stock issued for services (in shares)	2,429,555
Common stock issued for prepaid services	$ 717	189,158			189,875
Common stock issued for prepaid services (in shares)	716,667
Net loss			(2,172,242)		(2,172,242)
Balance at Jul. 31, 2014	$ 51,153	3,337,911	(4,757,633)		$ (1,368,569)
Balance (in shares) at Jul. 31, 2014	51,151,766				51,151,766
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common stock issued for cash	$ 600	37,390			$ 37,990
Common stock issued for cash (in shares)	600,000
Common stock issued for share based compensation	$ 43,425	521,110			564,535
Common stock issued for share based compensation (in shares)	43,425,743
Additional paid in capital from related party debt settlement		3,989			3,989
Common Stock issued for acquisition	$ 3,173	38,070			41,243
Common Stock issued for acquisition (in shares)	3,172,554
Common stock issued for related party AES Purchase	$ 44,118	(40,415)			3,703
Common stock issued for related party AES Purchase (in shares)	44,117,647
Common stock for conversion of convertible note principal	$ 19,013	117,744			136,757
Common stock for conversion of convertible note principal (in shares)	19,014,177
Gain or (Loss) on Derivative Liability		143,338			143,338
Other Comprehensive Income: Foreign Currency Items				$ (113)	113
Net loss			(1,121,222)		(1,121,222)
Balance at Apr. 30, 2015	$ 161,482	$ 4,159,137	$ (5,878,855)	$ (113)	$ (1,558,349)
Balance (in shares) at Apr. 30, 2015	161,481,887				161,481,887

Condensed Consolidated Statemen

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014
OPERATING ACTIVITIES
Net (Loss)	$ (1,121,222)	$ (1,553,329)
Adjustments to reconcile net (loss) to net cash from operating activities:
Allowance for bad debt	(4,000)	(5,772)
Gain (loss) on derivative	(49,878)	6,598
Amortization of debt discount	156,939	13,643
Short-term loan issued for professional fees		50,000
Depreciation expense	5,772	5,585
Share based compensation-common stock	564,535	807,852
Changes in operating assets and liabilities:
Accounts receivable	5,069	(15,727)
Other assets	(20,709)	56,796
Advances on Royalties		(140,000)
Inventory	135,399	32,729
Deferred revenue	(22,936)	160,849
Accounts payable and accrued expenses	(25,470)	(19,539)
Net Cash (Used) From Operating Activities	(376,501)	(600,315)
INVESTING ACTIVITIES
Net Cash (Used) Investing Activities		(1,670)
FINANCING ACTIVITIES
Repayments of related party payable	145	(3,356)
Proceeds from convertible debt	363,048	656,500
Repayment of loan payable	(31,285)	(29,726)
Proceeds from line of credit		26,000
Repayment of line of credit	3,136	(3,951)
Repayments of notes payable- related party	(36,608)	(7,070)
Affects of Exchange Rate from Cash	113
Sale of common stock	37,990
Net Cash provided by Financing Activities	336,539	638,397
Net Increase (Decrease) in Cash and Cash Equivalents	(39,962)	36,412
Cash and Cash Equivalents, Beginning of Period	79,235	11,129
Cash and Cash Equivalents, End of Period	39,273	47,541
Cash paid during the period for:
Interest	4,448	1,811
Non-cash Investing and Financing activities:
Common stock for conversion of convertible note principal	136,757
Debt Discount	169,514	78,500
Gain or (Loss) on Derivative Feature	143,338
Stock issued for Acquisition of Nutribrand	41,243
Stock Issued for the Acquisition of AES	$ 3,703
Stock Issued for Services		155,375
Stock Issued for Intangible asset		$ 60,900

ORGANIZATION AND BASIS OF PRESE

ORGANIZATION AND BASIS OF PRESENTATION	9 Months Ended
	Apr. 30, 2015
Organization And Basis Of Presentation [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION The condensed consolidated unaudited interim financial statements included herein have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). The condensed consolidated financial statements and notes are presented as permitted on Form 10-Q and do not contain information included in the Company's annual statements and notes. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures are adequate to make the information presented not misleading. It is suggested that these condensed consolidated financial statements be read in conjunction with the July 31, 2014 audited consolidated financial statements and the accompanying notes thereto. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. The preparation of financial statements in accordance with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the Company's consolidated condensed financial statements and accompanying notes. Actual results could differ materially from those estimates. These condensed consolidated unaudited financial statements reflect all adjustments, including normal recurring adjustments which, in the opinion of management, are necessary to present fairly the operations and cash flows for the periods presented. Health Education Corporation d.b.a. NutraNomics, Inc., (the "Company") was incorporated under the laws of the State of Delaware on February 14, 1996, and later reincorporated under the laws of the State of Utah on January 5, 1998. The Company was originally organized to provide education services, books, cassette tapes and public presentations. The Company utilized several revenue generating tools in order to accomplish this goal including Live Blood Analysis, iridology, bone density screening and other self-help methods. In 1998, the Company changed its incorporation to the State of Utah, the primary place of business. In 2001, the Company created its own line of nutritional products that quickly became its leading revenue source. The Company filed for the d.b.a. of NutraNomics, Inc., in order to fully prepare and utilize the brand name for expansion. In retail outlets and to its clientele, the Company is known as NutraNomics, Inc. The Company sells its own brand of supplements in 16 countries direct to the public. Beyond its sales in both the United States and Canada, the Company maintains sales representatives in Taiwan, Japan, Singapore, Philippines, Malaysia and South Korea. The Company maintains multiple different trademarks, trade names and patents. Merger On September 13, 2013, Buka Ventures, Inc., a Nevada corporation ("Buka") and Health Education Corporation dba. Nutranomics, Inc., a Utah corporation ("Nutranomics"), executed and delivered a Share Exchange Agreement (the "Share Agreement") and all required or necessary documentation to complete a merger (collectively, the "Transaction Documents"), whereby Buka became the parent company and Nutranomics became the wholly-owned subsidiary on the closing of the Share Agreement. Prior to the closing of this transaction and pursuant to a certain Share Exchange Agreement dated September 13, 2013, Buka canceled 25,000,000 of its 46,500,000 issued and outstanding common shares and simultaneously issued 25,005,544 shares of its common stock in exchange for 8,994,800 shares of Nutranomics common stock. The merger has been treated as a reverse acquisition and a recapitalization of a public company. Accordingly, the historic financial statements of the Company are the historic financial statements of Nutranomics, which was incorporated on January 5, 1998. On January 26, 2015, Nutranomics, Inc. (the "Company") entered into a Share Exchange Agreement with Nutriband Ltd., an Irish private limited company ("Nutriband"), and its shareholders to acquire 100% of Nutriband in exchange for (1) the issuance of 3,172,554 shares of the Company's common stock to Nutriband's shareholder, Gareth Sheridan, and (2) the payment of a perpetual 10% royalty on gross global sales of all Nutriband products to the Nutriband shareholders. The following table summarizes the consideration given for Nutriband and the fair values of the assets acquired and liabilities assumed recognized at the acquisition date. The entire amount of the excess of the estimated consideration given over the working capital acquired, has been provisionally allocated to goodwill. Consideration Given: Common Stock $ 41,243 Total consideration $ 41,243 Fair value of identifiable assets acquired and liabilities assumed: Cash $ 271 Identified intangible assets $ 223 Total identifiable net assets $ 494 Goodwill and unidentified intangible assets $ 40,749

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Apr. 30, 2015
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Loss per Share Basic loss per share ("EPS") is computed by dividing net loss (the numerator) by the weighted-average number of common shares outstanding for the period (the denominator). Diluted EPS is computed by dividing net loss by the weighted-average number of common shares and potential common shares outstanding (if dilutive) during each period. Potential common shares include common shares to be issued related to convertible debentures and stock pending issue under the ratchet provision. As the Company has incurred losses for the nine months ended April 30, 2015 and 2014, the potentially dilutive shares are anti-dilutive and are thus not added into the loss per share calculations. As of April 30, 2015, there were 249,636,981 anti-dilutive shares related to convertible notes based on their terms and conditions with none related to warrants. Going Concern The Company's financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has generally had net losses after consideration of income taxes. Further, the Company has negative working capital and insufficient cash flows from operation as of April 30, 2015, and does not have the requisite liquidity to pay its current obligations. These factors, among others, raise substantial doubt about its ability to continue as a going concern. Management will seek to increase revenues and reduce costs, while raising capital through the sale of its stock. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("US GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates and assumptions are based on management's best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the economic environment, which management believes to be reasonable under the circumstances. Management adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates. Derivative Liabilities In connection with the private placement of certain convertible notes beginning in January 2014, the Company became contingently obligated to issue shares of common stock in excess of the 750 million authorized under the Company's certificate of incorporation. Consequently, the ability to settle these obligations with common shares would be unavailable causing these obligations to potentially be settled in cash. This condition creates a derivative liability. The Company has a sequencing policy regarding share settlement wherein instruments with the earliest issuance date would be settled first. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split, to have an issuance date to coincide with the event giving rise to the additional shares. Using this sequencing policy, all instruments convertible into common stock, including warrants and the conversion feature of notes payable, issued subsequent to January 14, 2014 are derivative liabilities. The Company values these convertible notes payable using the multinomial lattice method that values the derivative liability within the notes based on a probability weighted discounted cash flow model. The resulting liability is valued at each reporting date and the change in the liability is reflected as change in derivative liability in the statement of operations. Revenue Recognition Our revenue is derived from the service revenue from Live Blood Analysis, sale of retail products, and revenue derived from educational services. The Company's revenue recognition policy is in accordance with the requirements of Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition ("SAB 104"), and other applicable revenue recognition guidance under US GAAP. Sales revenue is recognized for our retail and wholesale customers when: (i) persuasive evidence of a sales arrangement exists, (ii) the sales terms are fixed or determinable, (iii) title and risk of loss have transferred, and (iv) collectability is reasonably assured — generally when products are shipped to the customer and services are rendered, except in situations in which title passes upon receipt of the products by the customer. In this case, revenues are recognized upon notification that customer receipt has occurred. The Company accrues an estimated amount for sales returns and allowances related to defective or returned products at the time of sale based on its ability to estimate sales returns and allowances using historical information. For the nine months ended April 30, 2015 and 2014, the Company calculated the amount to be less than 1% of sales so no allowance was accrued in either year. Shipping and handling fees and related freight costs and supplies associated with shipping products to customers are included as a component of cost of sales. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as unearned revenue. The Company also recognizes revenues from the distribution of its product through trade partners. Related revenues consist of product costs, distribution fees, testing and labeling costs, as well as any associated administrative fees. The Company recognizes these revenues after the product has been shipped from the outsource manufacturer to the trade partner. The Company has contractual obligation to pay the outsource manufacturers, and as a principal in these arrangements the Company includes the total product price as revenue in accordance with applicable accounting guidance. The Company has separately negotiated contractual relationships with its trade partners, and under contracts with these trade partners the Company assumes the credit risk of product produced by the outsource manufacturer and dispensed to the trade partner. Unearned Revenues consist of cash received in advance for products to be delivered at a future date. The Company records the payments received as a liability until the products are delivered. The Company recorded unearned revenue of $315,327 and $338,263 as of April 30, 2015 and July 31, 2014, respectively. Cost of Sales The Company includes product costs (i.e. material, direct labor and overhead costs), shipping and handling expense, insurance on inventory, production-related depreciation expense and product license agreement expense in cost of sales.

COMMITMENTS, CONTINGENCIES AND

COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS	9 Months Ended
	Apr. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS	NOTE 3 – COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS On March 20, 2014, the Company's subsidiary, Health Education Corporation ("Health Education"), was served a copy of a complaint filed by EpicEra Incorporated ("Epic") in the Utah Third Judicial District Court for the return of a $100,000 deposit paid by Epic to Health Education for the supply of nutritional products. On April 16, 2014, Health Education answered the Complaint and filed a counterclaim against Epic and third-party claims against eCosway USA, Inc. ("eCosway," which is Epic's owner), and its principals, for breach of a non-disclosure and non-circumvention agreement, unjust enrichment, fraud, and fraudulent nondisclosure. Health Education's claims alleged that (1) eCosway and its principals have defrauded Health Education and engaged in a scheme of corporate espionage to misappropriate Health Education's proprietary information and trade secrets to launch their new multilevel marketing company, Epic; (2) under the fraudulent guise of partnering with Health Education to have Health Education formulate and produce the health products to be sold by Epic's distributors, eCosway and its principals signed a non-disclosure and non-circumvention agreement that they had no intention of honoring in order to gain access to Health Education's proprietary information so that they could steal that information and use it for their own benefit; (3) Health Education relied upon the non-disclosure and non-circumvention agreement and misrepresentations of Epic, eCosway, and its principals, and disclosed the proprietary information and formulations, which Epic then appropriated as its own. Health Education's claims request general damages as well as punitive damages. On May 6, 2015, fact discovery concluded, and expert discovery has also concluded. Epic filed a motion for summary judgment on or about June 2, 2015, Health Education opposed the motion on or about June 19, 2015, and a hearing has been scheduled for September 9, 2015. On January 16, 2015, the Company was served a copy of a complaint filed by NHK Laboratories, Inc., in the Superior Court of California, County of Los Angeles, arising out of an alleged breach of contract by the Company and seeking $79,769.92 in principal, plus interest and attorney fees. The Company retained local counsel who answered the complaint, and the case is currently in the discovery phase.

LEASES

LEASES	9 Months Ended
	Apr. 30, 2015
Leases [Abstract]
LEASES	NOTE 4 – LEASES The Company leases a 3,000 square foot office in the Draper, Utah that serves as its principal executive offices was renewed on December 15, 2014 for 2 years. Pursuant to the lease, the rent for the nine months ended April 30, 2015 and 2014, totaled $37,475 and $35,910, respectively. The Company has the ability to sublease three rooms totaling 1,500 square feet of their Draper office space on a month to month basis. The company subleased only one room during 2014 and terminated that sublease prior to 2015 . Pursuant to the sublease agreements, the monthly rent received for the totaled $0 and The Company leased certain machinery and equipment in 2013 and 2012 under an agreement that is classified as an operating lease. The lease expired on July 15, 2013, and is now leased on a month-to-month basis. Rent expense under the operating lease totaled $2,648 and $3,277 at for the nine months ended April 30, 2015 and 2014, respectively. The future minimum lease payments required under the operating leases as of July 31, 2014, are as follows: Year Ended July 31, Amount 2015 $ 39,000 2016 40,500 2017 - 2018 - Thereafter - Total lease obligations $ 79,500

RELATED PARTY NOTES PAYABLE

RELATED PARTY NOTES PAYABLE	9 Months Ended
	Apr. 30, 2015
Related Party Notes Payable [Abstract]
RELATED PARTY NOTES PAYABLE	NOTE 5 – RELATED PARTY NOTES PAYABLE In January 2012, the Company entered into a two year, zero percent note with an 8% imputed interest rate with a director in the amount of $150,000. The note was due on December 31, 2014. The Company agreed to pay royalty payments in connection with sales of a certain product line. As of July 31, 2014 the balance on the related part note was $36,608. On December 12, 2014, the Company settled its related party note payable in the amount of $35,036 with a Company director in exchange for $30,000 cash, additional paid in capital of $3,989, and offsets of $1,138 in related party liabilities.

RELATED PARTY PAYABLE

RELATED PARTY PAYABLE	9 Months Ended
	Apr. 30, 2015
Related Party Transactions [Abstract]
RELATED PARTY PAYABLE	NOTE 6 – RELATED PARTY PAYABLE Related party payables consist of payments made by a director through credit cards and use of a line of credit used to pay expenses on behalf of the Company. During the nine months ended April 30, 2015 and 2014, the officer lent $0 and $0 and the Company made payments of $3,844 and $9,019, respectively. As of April 30, 2015 and July 31, 2014, the Company owed a total of $17,239 and $21,083 in related party payables.

LINES OF CREDIT AND LOAN PAYABL

LINES OF CREDIT AND LOAN PAYABLE	9 Months Ended
	Apr. 30, 2015
Debt Disclosure [Abstract]
LINES OF CREDIT AND LOAN PAYABLE	NOTE 7 – LINES OF CREDIT AND LOAN PAYABLE The Company maintains a Line of Credit with Key Bank (the "Lender"). The Line of Credit was opened on August 28, 2012, with an available $250,000 to be drawn on for one year, not to exceed the principal amount ("draw period"). Once the draw period is completed, advances will no longer be permitted and the Company shall repay the principal and interest outstanding, over 5 years ("repayment period"). The repayment period begins August 28, 2013, after which a minimum monthly payment amount will be determined. The initial interest rate is 5.210%, and is variable. The variable interest rate is based on an independent index which is the "prime rate" as published each business day in the "Money Rates" column of the Wall Street Journal. Interest on the note is computed on a 365/365 simple interest basis, using 1.960% points over the index. The Lender executed a commercial security agreement. With this agreement, the Lender is entitled to a security interest in the Company's inventory, chattel paper, accounts receivable and general intangibles. In August 2013, the line of credit was converted into a note, and the Company is no longer able to borrow any additional funds. Under the new terms of the note, the note has a face value of $250,000 that matures on September 1, 2018, with an interest rate of prime plus 1.960%, and as of the date of the note, the interest rate was 5.21%. The note has minimum monthly payments of $4,745 which started on October 1, 2013. The balance outstanding on this note and line of credit as of April 30, 2015 and July 31, 2014, was $177,615 and $208,901, respectively. As of April 30, 2015, the Company has paid $72,385 in principal payments. The Lender allowed the Company to absorb a prior $50,000 note into the note, not affecting the repayment date. The Company did incur issuance costs of $4,037, which were expensed upon occurrence. Loans payable consisted of the following as of April 30, 2015 and July 31, 2014: Loan Payable April 30, July 31, 2015 2014 $250,000 face value, converted from a LOC on August 28, 2013, interest rate of 5.21%, matures on September 1, 2018. $ 177,615 $ 208,901 Total Loan payable 177,616 208,901 Less current portion 35,426 51,071 Loan payable, long-term $ 142,190 $ 157,830 In 1998, the Company entered into a line of credit with Zions Bank ("Lender") with a credit limit of $40,000. The line bears a compounding per annum fixed interest rate of 5.25%. As of April 30, 2015 and July 31, 2014, the Company owed $36,234 and $33,098 in principal, respectively. The Lender executed a commercial security agreement. With this agreement, the Lender is entitled to a security interest in the Company's inventory, chattel paper, accounts receivable and general intangibles. The Company did incur a setup fee, which has been fully amortized. There is no term limit on the line and the Company is allowed to draw up to its dollar limit. The loan payable was defaulted on April 28, 2015 and corrected on June 10, 2015 with an extention fee of $1,590 and legal fees of $1,429.

CONVERTIBLE NOTES PAYABLE AND L

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE	9 Months Ended
	Apr. 30, 2015
Convertible Notes Payable And Loan Payable [Abstract]
CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE	NOTE 8 – CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE Convertible notes payable consisted of the following as of April 30, 2015 and July 31, 2014, respectively: Convertible Notes Payable April 30, July 31, 2015 2014 $250,000 face value, issued on September 27, 2013, interest rate of 10%, matures on September 27, 2015. $ 250,000 $ 250,000 $125,000 face value, issued on October 18, 2013, interest rate of 10%, matures on October 18, 2015. 125,000 125,000 $150,000 face value, issued on November 22, 2013, interest rate of 10%, matures on November 22, 2015. 150,000 150,000 $78,500 face value, of which, $78,500 was converted, issued on January 14, 2014, interest rate of 8% and a default rate of 22%, matured on October 14, 2014, net of unamortized discount of $29,759 and $78,500 as of April 30, 2015 and July 31, 2014. - 29,759 $53,000 face value, of which, $53,000 was converted, issued on March 19, 2014, interest rate of 8% and a default rate of 22%, matured on December 26, 2014, net of unamortized discount of $13,913 and $33,000 as of April 30, 2015 and July 31, 2014. - 13,913 $63,000 face value, issued on May 15, 2014, interest rate of 8%, and a default rate of 22%, matured on February 2, 2015, net of unamortized discount of $0 and $47,673 as of April 30, 2015 and July 31, 2014. 63,000 15,327 $73,500 face value, issued on December 2, 2014, interest rate of 8%, matures on December 2, 2015, net of unamortized discount of $43,496 and $0 as of April 30, 2015 and July 31, 2014. 30,004 - $59,000 face value, issued on December 2, 2014, interest rate of 8%, matures on September 2, 2016, net of unamortized discount of $45,264 and $0 as of April 30, 2015 and July 31, 2014. 13,736 - $65,000 face value, issued on December 16, 2014, interest rate of 0%, matures on December 16, 2016, net of unamortized discount of $52,996 and $0 as of April 30, 2015 and July 31, 2014. 12,004 - $33,000 face value, issued on March 17, 2015, interest rate of 8% maturing on December 19, 2015, net of unamortized discount of $27,758 and $0 as of April 30, 2015 and July 31, 2014. 5,242 Total convertible notes payable – non-related parties 648,986 583,999 Current Portion of Notes 637,074 174,500 Discount on Notes 169,514 115,501 Convertible notes payable-current portion net of discount 467,560 58,999 Convertible notes payable, long-term $ 181,426 $ 525,000 On September 27, 2013, the Company issued a convertible note to an unrelated party for $250,000 that matures in September 27, 2015. The note bears an interest rate of 10% per annum with a floor of $.005 per share, and principal is convertible at any time after September 27, 2013 in part or in whole into shares of the Company's common stock using the average closing prices for five trading days directly preceding the conversion date. Interest is not convertible and is due upon conversion or at maturity date. On October 18, 2013, the Company issued a convertible note to an unrelated party for $125,000 that matures in October 18, 2015. The note bears an interest rate of 10% per annum with a floor of $.005 per share, and principal is convertible at any time after October 18, 2013 in part or in whole into shares of the Company's common stock using the average closing prices for five trading days directly preceding the conversion date. Interest is not convertible and is due upon conversion or at the maturity date. On November 22, 2013, the Company issued a convertible note to an unrelated party for $150,000 that matures in November 22, 2015. The note bears an interest rate of 10% per annum with a floor of $.005 per share, and principal is convertible at any time after November 22, 2013 in part or in whole into shares of the Company's common stock using the average closing prices for five trading days directly preceding the conversion date. Interest is not convertible and is due upon conversion or at the maturity date. On January 14, 2014, the Company entered into a convertible promissory note with Asher Enterprises, Inc. ("Asher") a Delaware corporation for an 8% convertible promissory note with an aggregate principal amount of $78,500 which together with any unpaid accrued interest is due on October 17, 2014. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the Market Price, which means the average of the lowest three Trading Prices (defined as the closing bid prices) during the ten trading day period ending on the last complete trading day prior to the conversion date with a floor of $.00005 as stated in the conversion feature. In January 2014, the Company received cash in the amount of $58,600, with the remaining $19,900 being used for legal and accounting fees. The Company analyzed the note on the issuance date on January 14, 2014. The Company determined that the variable conversion price and the floor exceeding the authorized number of shares results in the need for bifurcation into a separate derivative liability valued at fair market value. On January 14, 2014, the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $87,968 and a discount on the note of $78,500. On September 24, 2014, Asher converted $15,000 of principal related to the January 14, 2014, convertible note into 583,658 shares of the Company's common stock at $0.0257 per share. On October 2, 2014, Asher converted an additional $15,000 of principal related to the January 14, 2014, convertible note into 810,811 shares of the Company's common stock at $0.0185 per share. On October 9, 2014, Asher converted an additional $12,000 of principal related to the January 14, 2014, convertible note, into 869,565 shares of the Company's common stock at $0.0138 per share. The remaining principal balance due after the conversions was $36,500. On March 19, 2014, the Company entered into a convertible promissory note with KBM Worldwide, Inc. ("KBM") a New York corporation for an 8% convertible promissory note with an aggregate principal amount of $53,000 which together with any unpaid accrued interest is due on December 26, 2014. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the Market Price, which means the average of the lowest three Trading Prices (defined as the closing bid prices) during the three trading day period ending on the last complete trading day prior to the conversion date with a floor of $.00005 as stated in the conversion feature. In March 2014, the Company received cash in the amount of $24,487, with the remaining $6,898 being used for legal and accounting fees. The Company analyzed the note on the issuance date on January 14, 2014. The Company determined that the variable conversion price and the floor exceeding the authorized number of shares results in the need for bifurcation into a separate derivative liability valued at fair market value. On March 19, 2014, the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $47,806 and a discount on the note of $49,010. On May 15, 2014, the Company entered into a convertible promissory note with KBM Worldwide, Inc. ("KBM") a New York corporation for an 8% convertible promissory note with an aggregate principal amount of $63,000 which together with any unpaid accrued interest is due on February 2, 2015. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the Market Price, which means the average of the lowest three Trading Prices (defined as the closing bid prices) during the three trading day period ending on the last complete trading day prior to the conversion date with a floor of $.00005 as stated in the conversion feature. In May 2014, the Company received cash in the amount of $42,500, with the remaining $17,500 being used for legal fees. The Company analyzed the note on the issuance date on January 14, 2014. The Company determined that the variable conversion price and the floor exceeding the authorized number of shares results in the need for bifurcation into a separate derivative liability valued at fair market value. On May 15, 2014, the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $56,591 and a discount on the note of $56,591. On November 14, 2014, Asher converted an additional $15,000 of principal related to the January 14, 2014, convertible note, into 931,677 shares of the Company's common stock at $0.0161 per share. The remaining principal balance due after the conversion was $21,500. On December 8, 2014, Asher converted an additional $12,500 of principal related to the January 14, 2014, convertible note, into 1,041,667 shares of the Company's common stock at $0.012 per share. The remaining principal balance due after the conversion was $9,000. On December 2, 2014, the Company entered into a collateralized secured convertible promissory note with LG Capital Funding, LLC ("LG"), a New York limited liability company, for an 8% convertible promissory note with an aggregate principal amount of $73,500, which together with any unpaid accrued interest is due on December 2, 2015. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the average of the lowest three closing bid prices during the ten trading day period ending on the conversion date. This note was funded on December 10, 2014, when the Company received cash in the amount of $70,000, with the remaining $3,500 being used for LG's legal and other origination expenses. On December 2, 2014, the Company also entered into a second $73,500 convertible promissory note with LG on the same terms as the first note and due on December 2, 2015, which has not yet been funded. This note is collateralized by a secured promissory note issued by LG to the Company for $73,500, due on August 2, 2015, and accruing interest at the rate of 8% per annum. This note was canceled along with the derivative liability on June 3, 2015 due to the fact that the Company had not maintained a stock price in excess of .002 at all times. On December 2, 2014, the Company entered into a collateralized secured convertible promissory note with Typenex Co-Investment, LLC ("Typenex"), a Utah limited liability company, for an 10% convertible promissory note with an aggregate principal amount of $224,000, of which the company is to assume $20,000 in original interest discount ("OID") and legal fees and other expenses of Typenex totaling $4,000, which together with any unpaid accrued interest is due on September 10, 2016. The note is to be issued in tranches with an initial tranche of $59,000, of which the company received $50,000 on December 10, 2014, with the remaining $4,000 being used for legal and other expenses of Typenex and the Company assuming $5,000 in OID. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at a variable conversion price calculated as 58% of the average of the lowest three closing bid prices during the ten trading day period ending on the last complete trading day prior to the conversion date. The remaining three tranches of $55,000 of funding to the Company under the note will consist of $50,000 in principal and the $5,000 in OID, which have not yet been funded, and shall correspond to three $50,000 promissory notes issued by Typenex in favor of the Company, accruing interest at 8% per annum and maturing on September 2, 2016. In conjunction with the Company's convertible note issued to Typenex and Typenex's three promissory notes issued to the Company for the three additional tranches of funding to the Company, the Company issued four warrants for a total number of shares equal to $112,000 ($29,500 for the first warrant corresponding to funding on December 10, 2014, and $27,500 for the other three warrants corresponding to the future tranches of funding by Typenex to the Company) divided by the conversion market price in the Typenex convertible note. The warrants have an exercise price of $0.06, subject to adjustment, and expire on December 2, 2019. Each of the warrants are only exerciseable after the corresponding tranche of funding by Typenex to the company has been paid. Therefore, the first warrant is currently exerciseable, but the other three warrants are not. On December 10, 2014, the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $84,512 and a discount on the note of $59,000. On December 2, 2014, the Company entered into a convertible promissory note with JMJ Financial, a Nevada sole proprietorship ("JMJ"), with a face amount of $350,000, of which the company is to assume $35,000 in original interest discount ("OID"), which together with any unpaid accrued interest is due on Dec 2, 2016. The note is to be funded by JMJ at its discretion, and the initial tranche was funded on December 16, 2014, when the Company received cash in the amount of $55,000. The note balance funded (plus a pro rata portion of the OID) together with any unpaid accrued interest is convertible into shares of common stock at a variable conversion price calculated as 65% of the average of the lowest trade price during a 25-day period ending on the last complete trading day prior to the conversion date. On December 16, 2014, the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $71,321 and a discount on the note of $65,000. On December 23, 2014, Asher converted an additional $12,500 of principal related to the January 14, 2014, convertible note, into 1,686,111 shares of the Company's common stock at $0.0072 per share. The remaining principal balance due after the conversion was $0. On , KBM converted $5,000 of principal related to the March 19, 2014, convertible note, into shares of the Company's common stock at $0.0056 per share. The remaining principal balance due after the conversion was $48,000. On January 26, 2015, KBM converted $15,000 of principal related to the March 19, 2014, convertible note, into shares of the Company's common stock at $0.0058 per share. The remaining principal balance due after the conversion was $33,000. On , KBM converted $11,455 of principal related to the March 19, 2014, convertible note, into shares of the Company's common stock at $0.0041 per share. The remaining principal balance due after the conversion was $21,545. On , KBM converted $9,055 of principal related to the March 19, 2014, convertible note, into shares of the Company's common stock at $0.0038 per share. The remaining principal balance due after the conversion was $12,490. On , KBM converted $12,490 of principal and $2,120 related to the March 19, 2014, convertible note, into shares of the Company's common stock at $0.0056 per share. The remaining principal balance due after the conversion was $0. On March 17, 2015, the Company entered into a convertible promissory note with for an 8% convertible promissory note with an aggregate principal amount of $33,000 which together with any unpaid accrued interest is due on December 19, 2015. This convertible note together with any unpaid accrued interest is convertible into shares of common stock at the holder's option 180 days from inception at a variable conversion price calculated as 58% of the Market Price, which means the average of the lowest three Trading Prices (defined as the closing bid prices) during the three trading day period ending on the last complete trading day prior to the conversion date with a floor of $.00005 as stated in the conversion feature. On April 1, 2015 the Company received cash in the amount of $20,000, with the remaining $13,000 being used for legal fees. The Company analyzed the note on the issuance date on March 17, 2015. The Company determined that the variable conversion price and the floor exceeding the authorized number of shares results in the need for bifurcation into a separate derivative liability valued at fair market value. On April 30, 2015 the Company estimated the fair market value of the derivative liability associated with the bifurcated conversion feature to be $35,444 and a discount on the note of $33,000. As of April 30, 2015 and July 31, 2014, the Company estimated the fair market value of the derivative liability to be $188,391 and $177,907, with a change in fair value of $49,878 respectively. For the nine months ended April 30, 2015 and 2014, the Company recorded $156,939 and $13,643 in amortization related to the discount on the note to interest expense and $9,602 and $0 in interest related to the nine conversions. See note 12.

INCOME TAXES

INCOME TAXES	9 Months Ended
	Apr. 30, 2015
Income Tax Disclosure [Abstract]
INCOME TAXES	NOTE 9 – INCOME TAXES The tax provision for interim periods is determined using an estimate of the Company's effective tax rate for the full year adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter the Company updates its estimate of the annual effective tax rate, and if the estimated tax rate changes, the Company makes a cumulative adjustment. At April 30, 2015 and July 31, 2014, the Company has a full valuation allowance against its deferred tax assets as it believes it is more likely than not that these benefits will not be realized. The Company files income tax returns in the U.S. federal tax jurisdiction and state of Utah tax jurisdiction. The tax year for 2014 remains open for federal and/or state tax jurisdictions.

STOCK TRANSACTIONS

STOCK TRANSACTIONS	9 Months Ended
	Apr. 30, 2015
Stockholders' Equity Note [Abstract]
STOCK TRANSACTIONS	NOTE 10 – STOCK TRANSACTIONS As of April 30, 2015 and July 31, 2014, the Company has 750,000,000 shares of common stock authorized with a par value of $.001, and 161,481,887 and 51,151,766 shares of common stock issued and outstanding, respectively. During the nine months ended April 30, 2015, the Company issued 600,000 shares of common stock as part of the Equity Purchase Agreement described below for cash for $37,990. During the nine month period ended April 30, 2015, the Company issued 19,014,177 shares of common stock related to convertible notes. The Asher convertible note issued January 14, 2014 for $78,500 in principal was fully converted into common stock. The first conversion, on September 24, 2014, converted $15,000 of principal into 583,658 shares of the Company's common stock at $0.0257 per share. The second conversion, on October 2, 2014, converted an additional $15,000 of principal into 810,811 shares of the Company's common stock at $0.0185 per share. The third conversion, on October 9, 2014, converted an additional $12,000 of principal into 869,565 shares of the Company's common stock at $0.0138 per share. The f ourth conversion, on November 14, 2014, converted an additional $15,000 of principal into 931,677 shares of the Company's common stock at $0.0521 per share. The fifth conversion, on December 12, 2014, converted an additional $12,500 of principal into 1,041,667 shares of the Company's common stock at $0.012 per share. The sixth conversion, The KBM Worldwide note issued on March 19, 2014 for $53,000 in principal had two principal conversions for $20,000. The first conversion on January 20, 2015, converted $5,000 of principal into 892,857 shares of the Company's common stock at $$0.0056 per share. The second conversion on January 26, 2015, converted an additional $15,000 in principal into 2,586,207 shares of the Company's common stock at $$0.0058 per share. 9,055 0.0038 12,490 $2,120 interest 0.0033 The remaining principal balance due after the conversions was $0. During the nine month period ended April 30, 2015, the Company also issued 90,715,944 shares of Common Stock for share-based compensation, acquisitions, and consulting services. On January 29, 2015, the Company completed the acquisitions of Nutriband and the AES™ intellectual property by issuing (1) 3,172,554 shares of the Company's common stock to Gareth Sheridan, and (2) 44,117,647 shares of the Company's common stock to Dr. Gibbs's family partnership, the Zen Family LP. On January 29, 2015, the Company issued 5,000,000 shares of the Company's common stock to Alta Nordic LLC, an entity controlled by Michael Doron, our CEO and director, in consideration for Mr. Doron's previous appointment to the Company's Board of Directors. On January 29, 2015, the Company issued 2,500,000 shares of the Company's common stock to Alta Nordic LLC in consideration for Mr. Doron's negotiation and closing of the Nutriband acquisition. On January 29, 2015, the Company issued 30,157,463 shares of the Company's common stock to Alta Nordic LLC in satisfaction of the Company's obligations to Mr. Doron under the Company's employment contract with Mr. Doron. On January 29, 2015, the Company issued 5,768,280 shares of the Company's common stock to Chienn Consulting Company for general business and marketing consulting services rendered during the quarter. Equity Purchase Agreement The Company entered into an equity purchase agreement with Southridge Partners II, LP ("Southridge") on December 9, 2013. Pursuant to the Equity Purchase Agreement, Southridge committed to purchase up to $10,000,000 of the Company's common stock, over a period of time terminating on the earlier of: (i) 24 months from the effective date of a registration statement to be filed in connection therewith or (ii) the date on which Southridge has purchased shares of common stock pursuant to this agreement for an aggregate maximum purchase price of $10,000,000; such commitment is subject to certain conditions. The purchase price to be paid by Southridge will be 90% of the average of the lowest three (3) daily volume weighted average prices for the Company's common stock for the ten (10) trading days immediately following clearing of the Estimated Put Shares (defined below) (such purchase price the "Put Purchase Price") under the Equity Purchase Agreement. The Company will deliver to Southridge, simultaneously with delivery of a Put Notice, a number of Shares equal to 125% of the Investment Amount divided by the closing price of the Company's common stock on the day preceding the Put Notice date (the "Estimated Put Shares"). The actual number of Shares purchased by Southridge for the Investment Amount shall then be calculated by dividing the Investment Amount by the Put Purchase Price. Any excess Estimated Put Shares shall then be returned to the Company. The number of Shares sold to Southridge at any time shall not exceed the number of such shares that, when aggregated with all other shares of common stock of the Company then beneficially owned by Southridge, would result in Southridge owning more than 9.99% of all of the Company's common stock then outstanding. Also as part of the equity purchase agreement, the Company issued a promissory note to Southridge for $50,000, with 0% interest. This note matures on May 31, 2014 and is not convertible into common stock. Finally, as part of the equity purchase agreement, Southridge is prohibited from executing any short sales of the Company's common stock during the term of the equity purchase agreement. The Company will not be entitled to put shares to Southridge: · unless there is an effective registration statement under the Securities Act to cover the resale of the shares by Southridge; · unless the common stock continues to be quoted on the OTC Bulletin Board and has not been suspended from trading; · if an injunction shall have been issued and remain in force, or action commenced by a governmental authority which has not been stayed or abandoned, prohibiting the purchase or the issuance of the shares to Southridge; · if the Company has not complied with their obligations and are otherwise in breach of or in default under, the Equity Purchase Agreement, our registration rights agreement (the "Registration Rights Agreement") with Southridge or any other agreement executed in connection therewith with Southridge; · since the date of the filing of the Company's most recent filing with the Securities and Exchange Commission no event that had or is reasonably likely to have a Material Adverse Effect (as defined in the Equity Purchase Agreement) has occurred; and · to the extent that such shares would cause Southridge's beneficial ownership to exceed 9.99% of our outstanding shares. The Equity Purchase Agreement further provides that Southridge is entitled to customary indemnification from the Company for any losses or liabilities it suffers as a result of any breach of any provisions of the Equity Purchase Agreement or the Registration Rights Agreement, or as a result of any lawsuit brought by a third-party arising out of or resulting from Southridge's execution, delivery, performance or enforcement of the Equity Purchase Agreement or the Registration Rights Agreement or from material misstatements or omissions in the prospectus accompanying the registration statement for the resale of the shares issued to Southridge. As of April 30, 2015, 2,107,554 shares have been issued under the Equity Purchase Agreement representing $137,120 in cash received.

DERIVATIVE LIABILITY

DERIVATIVE LIABILITY	9 Months Ended
	Apr. 30, 2015
Derivative Liability [Abstract]
DERIVATIVE LIABILITY	NOTE 11 – DERIVATIVE LIABILITY FASB ASC 820 defines fair value, establishes a framework for measuring fair value under U.S. generally accepted accounting principles and enhances disclosures about fair value measurements. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value under FASB ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. The standard describes a fair value hierarchy based on three levels of inputs, with the first two inputs considered observable and the last input considered unobservable, that may be used to measure fair value as follows: · Level one -- Quoted market prices in active markets for identical assets or liabilities; · Level two – Inputs, other than level one inputs, that are either directly or indirectly observable; and · Level three -- Unobservable inputs developed using estimates and assumptions, which are developed by the reporting entity and reflect those assumptions that a market participant would use. Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosures each quarter. The Company has one liability measured at fair value on a recurring basis, which consists of a derivative liability on certain convertible notes payable (see note 11). As of April 30, 2015 this derivative liability had an estimated fair value of $188,391. The Company has no assets that are measured at fair value on a recurring basis. The following table presents information about our derivative liability, which was our only financial instrument measured at fair value on a recurring basis using significant inputs other than level one inputs that are either directly or indirectly observable (Level 2) as of April 30, 2015: Balance at July 31, 2014 $ 177,907 Conversions (172,582 ) Total (gains)losses included in earnings (49,878 ) Issuances 232,944 Balance at April 30, 2015 $ 188,391 The fair value of this derivative liability was calculated using the multinomial lattice models that value the derivative liability within the notes based on a probability weighted discounted cash flow model. These models are based on future projections of the various potential outcomes. The features in the notes that were analyzed and incorporated into the model included the conversion feature with the reset provisions; redemption provisions; and the default provisions. Assumptions used to calculate the fair value of the derivative liability were as follows: April 30, 2015 Expected term in years 0-.26 years Risk-free interest rates 0.01-0.28 % Volatility 194 -202 % Dividend yield 0 % In addition to the assumptions above, the Company also takes into consideration whether or not the Company would participate in another round of financing and if that financing is registered or not and what that stock price would be for the financing at that time. The Company will continue to adjust the derivative liability for changes in fair value until the notes matured on October 14, 2014, and mature on December 26, 2014 and February 2, 2015.

INDUSTRY SEGMENT, GEOGRAPHIC IN

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS	9 Months Ended
	Apr. 30, 2015
Segment Reporting [Abstract]
INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS	NOTE 12 – INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS Geographic Sales Regions We currently sell and distribute our products six geographic regions: North Asia, Greater China, South Asia/Pacific, Europe, Middle East, and Americas. The following table sets forth the revenue for each of the geographic regions for the three and nine months ended April 30, 2015 and 2014: Three Months Ended April 30, 2015 2014 Americas $ 211,066 48.81 % $ 441,739 61.63 % North Asia 2,135 0.49 6,623 0.92 Greater China 40,976 9.48 73,603 10.27 South Asia/Pacific 176,036 40.71 189,798 26.48 Europe 2,201 0.51 5,000 0.70 $ 432,414 100.00 % $ 716,763 100.00 % Nine Months Ended April 30, 2015 2014 Americas $ 718,860 53.44 % $ 1,425,517 73.34 % North Asia 13,973 1.04 33,417 1.72 Greater China 211,523 15.73 114,690 5.90 Middle East 46 - - - South Asia/Pacific 397,338 29.54 365,118 18.78 Europe 3,370 0.25 5,000 0.26 $ 1,345,110 100.00 % $ 1,943,742 100.00 The table below lists our equipment, net, by geographic area for both the three and nine months ended April 30, 2015 and July 31, 2014: April 30, 2015 July 31, 2014 Americas $ 10,583 100.00 % $ 16,355 100.00 % North Asia - - - - Greater China - - - - South Asia/Pacific - - - - Europe - - - - $ 10,583 100.00 % $ 16,355 100.00 % The table below lists revenue generated by each of the Company's product lines during the three and nine months ended April 30, 2015 and 2014: Three Months Ended April 30, 2015 2014 Product Sales $ 431,893 99.88 % $ 713,438 99.54 % NBA Services 521 0.12 3,325 0.46 Educational Services - - - - $ 432,414 100.00 % $ 716,763 100.00 % Nine Months Ended April 30, 2015 2014 Product Sales $ 1,337,130 99.41 % $ 1,929,028 99.24 % NBA Services 7,980 0.59 14,714 0.76 Educational Services - - - - $ 1,345,110 100.00 % $ 1,943,742 100.00 % Significant Customers Three customer's make up 36.7% and 37.2% of total sales as of the three months ended April 30, 2015 and 2014, respectively, and 32.6% and 46.1% of total sales as of the nine months ended April 30, 2015 and 2014, respectively.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Apr. 30, 2015
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 13 – SUBSEQUENT EVENTS Management has evaluated subsequent events through July 7, 2015, which is the date the financial statements were available to be issued. The Company identified the following subsequent events through July 7, 2015: On , 2015 KBM converted $12,890 of principal related to the April 30, 2014, convertible note, into shares of the Company's common stock at $0.0016 per share. The remaining principal balance due after the conversion was $50,110.

SUMMARY OF SIGNIFICANT ACCOUN20

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Apr. 30, 2015
Accounting Policies [Abstract]
Loss per Share	Loss per Share Basic loss per share ("EPS") is computed by dividing net loss (the numerator) by the weighted-average number of common shares outstanding for the period (the denominator). Diluted EPS is computed by dividing net loss by the weighted-average number of common shares and potential common shares outstanding (if dilutive) during each period. Potential common shares include common shares to be issued related to convertible debentures and stock pending issue under the ratchet provision. As the Company has incurred losses for the nine months ended April 30, 2015 and 2014, the potentially dilutive shares are anti-dilutive and are thus not added into the loss per share calculations. As of April 30, 2015, there were 249,636,981 anti-dilutive shares related to convertible notes based on their terms and conditions with none related to warrants.
Going Concern	Going Concern The Company's financial statements are prepared using generally accepted accounting principles applicable to a going concern that contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has generally had net losses after consideration of income taxes. Further, the Company has negative working capital and insufficient cash flows from operation as of April 30, 2015, and does not have the requisite liquidity to pay its current obligations. These factors, among others, raise substantial doubt about its ability to continue as a going concern. Management will seek to increase revenues and reduce costs, while raising capital through the sale of its stock. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("US GAAP") requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. These estimates and assumptions are based on management's best estimates and judgment. Management evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors, including the economic environment, which management believes to be reasonable under the circumstances. Management adjusts such estimates and assumptions when facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from those estimates.
Derivative Liabilities	Derivative Liabilities In connection with the private placement of certain convertible notes beginning in January 2014, the Company became contingently obligated to issue shares of common stock in excess of the 750 million authorized under the Company's certificate of incorporation. Consequently, the ability to settle these obligations with common shares would be unavailable causing these obligations to potentially be settled in cash. This condition creates a derivative liability. The Company has a sequencing policy regarding share settlement wherein instruments with the earliest issuance date would be settled first. The sequencing policy also considers contingently issuable additional shares, such as those issuable upon a stock split, to have an issuance date to coincide with the event giving rise to the additional shares. Using this sequencing policy, all instruments convertible into common stock, including warrants and the conversion feature of notes payable, issued subsequent to January 14, 2014 are derivative liabilities. The Company values these convertible notes payable using the multinomial lattice method that values the derivative liability within the notes based on a probability weighted discounted cash flow model. The resulting liability is valued at each reporting date and the change in the liability is reflected as change in derivative liability in the statement of operations.
Revenue Recognition	Revenue Recognition Our revenue is derived from the service revenue from Live Blood Analysis, sale of retail products, and revenue derived from educational services. The Company's revenue recognition policy is in accordance with the requirements of Staff Accounting Bulletin ("SAB") No. 104, Revenue Recognition ("SAB 104"), and other applicable revenue recognition guidance under US GAAP. Sales revenue is recognized for our retail and wholesale customers when: (i) persuasive evidence of a sales arrangement exists, (ii) the sales terms are fixed or determinable, (iii) title and risk of loss have transferred, and (iv) collectability is reasonably assured — generally when products are shipped to the customer and services are rendered, except in situations in which title passes upon receipt of the products by the customer. In this case, revenues are recognized upon notification that customer receipt has occurred. The Company accrues an estimated amount for sales returns and allowances related to defective or returned products at the time of sale based on its ability to estimate sales returns and allowances using historical information. For the nine months ended April 30, 2015 and 2014, the Company calculated the amount to be less than 1% of sales so no allowance was accrued in either year. Shipping and handling fees and related freight costs and supplies associated with shipping products to customers are included as a component of cost of sales. Payments received before all of the relevant criteria for revenue recognition are satisfied are recorded as unearned revenue. The Company also recognizes revenues from the distribution of its product through trade partners. Related revenues consist of product costs, distribution fees, testing and labeling costs, as well as any associated administrative fees. The Company recognizes these revenues after the product has been shipped from the outsource manufacturer to the trade partner. The Company has contractual obligation to pay the outsource manufacturers, and as a principal in these arrangements the Company includes the total product price as revenue in accordance with applicable accounting guidance. The Company has separately negotiated contractual relationships with its trade partners, and under contracts with these trade partners the Company assumes the credit risk of product produced by the outsource manufacturer and dispensed to the trade partner. Unearned Revenues consist of cash received in advance for products to be delivered at a future date. The Company records the payments received as a liability until the products are delivered. The Company recorded unearned revenue of $315,327 and $338,263 as of April 30, 2015 and July 31, 2014, respectively.
Cost of Sales	Cost of Sales The Company includes product costs (i.e. material, direct labor and overhead costs), shipping and handling expense, insurance on inventory, production-related depreciation expense and product license agreement expense in cost of sales.

ORGANIZATION AND BASIS OF PRE21

ORGANIZATION AND BASIS OF PRESENTATION (Tables)	9 Months Ended
	Apr. 30, 2015
Organization And Basis Of Presentation [Abstract]
Schedule of fair values of the assets acquired and liabilities assumed	Consideration Given: Common Stock $ 41,243 Total consideration $ 41,243 Fair value of identifiable assets acquired and liabilities assumed: Cash $ 271 Identified intangible assets $ 223 Total identifiable net assets $ 494 Goodwill and unidentified intangible assets $ 40,749

LEASES (Tables)

LEASES (Tables)	9 Months Ended
	Apr. 30, 2015
Leases [Abstract]
Schedule of future minimum lease payments required under the operating leases	Year Ended July 31, Amount 2015 $ 39,000 2016 40,500 2017 - 2018 - Thereafter - Total lease obligations $ 79,500

LINES OF CREDIT AND LOAN PAYA23

LINES OF CREDIT AND LOAN PAYABLE (Tables)	9 Months Ended
	Apr. 30, 2015
Lines Of Credit And Loan Payable [Abstract]
Schedule of loan payable	Loan Payable April 30, July 31, 2015 2014 $250,000 face value, converted from a LOC on August 28, 2013, interest rate of 5.21%, matures on September 1, 2018. $ 177,615 $ 208,901 Total Loan payable 177,616 208,901 Less current portion 35,426 51,071 Loan payable, long-term $ 142,190 $ 157,830

CONVERTIBLE NOTES PAYABLE AND24

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Tables)	9 Months Ended
	Apr. 30, 2015
Convertible Notes Payable And Loan Payable [Abstract]
Schedule of convertible notes payable	Convertible Notes Payable April 30, July 31, 2015 2014 $250,000 face value, issued on September 27, 2013, interest rate of 10%, matures on September 27, 2015. $ 250,000 $ 250,000 $125,000 face value, issued on October 18, 2013, interest rate of 10%, matures on October 18, 2015. 125,000 125,000 $150,000 face value, issued on November 22, 2013, interest rate of 10%, matures on November 22, 2015. 150,000 150,000 $78,500 face value, of which, $78,500 was converted, issued on January 14, 2014, interest rate of 8% and a default rate of 22%, matured on October 14, 2014, net of unamortized discount of $29,759 and $78,500 as of April 30, 2015 and July 31, 2014. - 29,759 $53,000 face value, of which, $53,000 was converted, issued on March 19, 2014, interest rate of 8% and a default rate of 22%, matured on December 26, 2014, net of unamortized discount of $13,913 and $33,000 as of April 30, 2015 and July 31, 2014. - 13,913 $63,000 face value, issued on May 15, 2014, interest rate of 8%, and a default rate of 22%, matured on February 2, 2015, net of unamortized discount of $0 and $47,673 as of April 30, 2015 and July 31, 2014. 63,000 15,327 $73,500 face value, issued on December 2, 2014, interest rate of 8%, matures on December 2, 2015, net of unamortized discount of $43,496 and $0 as of April 30, 2015 and July 31, 2014. 30,004 - $59,000 face value, issued on December 2, 2014, interest rate of 8%, matures on September 2, 2016, net of unamortized discount of $45,264 and $0 as of April 30, 2015 and July 31, 2014. 13,736 - $65,000 face value, issued on December 16, 2014, interest rate of 0%, matures on December 16, 2016, net of unamortized discount of $52,996 and $0 as of April 30, 2015 and July 31, 2014. 12,004 - $33,000 face value, issued on March 17, 2015, interest rate of 8% maturing on December 19, 2015, net of unamortized discount of $27,758 and $0 as of April 30, 2015 and July 31, 2014. 5,242 Total convertible notes payable – non-related parties 648,986 583,999 Current Portion of Notes 637,074 174,500 Discount on Notes 169,514 115,501 Convertible notes payable-current portion net of discount 467,560 58,999 Convertible notes payable, long-term $ 181,426 $ 525,000

DERIVATIVE LIABILITY (Tables)

DERIVATIVE LIABILITY (Tables)	9 Months Ended
	Apr. 30, 2015
Derivative Liability [Abstract]
Schedule of financial instrument measured at fair value on a recurring basis using significant inputs other than level one inputs	Balance at July 31, 2014 $ 177,907 Conversions (172,582 ) Total (gains)losses included in earnings (49,878 ) Issuances 232,944 Balance at April 30, 2015 $ 188,391
Schedule of assumptions used to calculate the fair value of the derivative liability	April 30, 2015 Expected term in years 0-.26 years Risk-free interest rates 0.01-0.28 % Volatility 194 -202 % Dividend yield 0 %

INDUSTRY SEGMENT, GEOGRAPHIC 26

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Tables)	9 Months Ended
	Apr. 30, 2015
Segment Reporting [Abstract]
Schedule of revenue for each of geographic regions	Three Months Ended April 30, 2015 2014 Americas $ 211,066 48.81 % $ 441,739 61.63 % North Asia 2,135 0.49 6,623 0.92 Greater China 40,976 9.48 73,603 10.27 South Asia/Pacific 176,036 40.71 189,798 26.48 Europe 2,201 0.51 5,000 0.70 $ 432,414 100.00 % $ 716,763 100.00 % Nine Months Ended April 30, 2015 2014 Americas $ 718,860 53.44 % $ 1,425,517 73.34 % North Asia 13,973 1.04 33,417 1.72 Greater China 211,523 15.73 114,690 5.90 Middle East 46 - - - South Asia/Pacific 397,338 29.54 365,118 18.78 Europe 3,370 0.25 5,000 0.26 $ 1,345,110 100.00 % $ 1,943,742 100.00
Schedule of equipment, net, by geographic area	April 30, 2015 July 31, 2014 Americas $ 10,583 100.00 % $ 16,355 100.00 % North Asia - - - - Greater China - - - - South Asia/Pacific - - - - Europe - - - - $ 10,583 100.00 % $ 16,355 100.00 %
Schedule of revenue generated by each of product lines	Three Months Ended April 30, 2015 2014 Product Sales $ 431,893 99.88 % $ 713,438 99.54 % NBA Services 521 0.12 3,325 0.46 Educational Services - - - - $ 432,414 100.00 % $ 716,763 100.00 % Nine Months Ended April 30, 2015 2014 Product Sales $ 1,337,130 99.41 % $ 1,929,028 99.24 % NBA Services 7,980 0.59 14,714 0.76 Educational Services - - - - $ 1,345,110 100.00 % $ 1,943,742 100.00 %

ORGANIZATION AND BASIS OF PRE27

ORGANIZATION AND BASIS OF PRESENTATION (Details) - Nutriband Ltd. ("Nutriband")	Jan. 26, 2015USD ($)
Consideration Given:
Common Stock	$ 41,243
Total consideration	41,243
Fair value of identifiable assets acquired and liabilities assumed:
Cash	271
Identified intangible assets	223
Total identifiable net assets	494
Goodwill and unidentified intangible assets	$ 40,749

ORGANIZATION AND BASIS OF PRE28

ORGANIZATION AND BASIS OF PRESENTATION (Detail Textuals)	Sep. 13, 2013shares	Apr. 30, 2015Countryshares	Jul. 31, 2014shares
Organization And Basis Of Presentation [Line Items]
Number of countries where company sells its products directly to public | Country		16
Number of common shares issued		161,481,887	51,151,766
Number of common shares outstanding		161,481,887	51,151,766
Reverse Acquisition And Recapitalization | Share Exchange Agreement | Buka Ventures Inc
Organization And Basis Of Presentation [Line Items]
Number of shares cancelled	25,000,000
Number of common shares issued	46,500,000
Number of common shares outstanding	46,500,000
Number of common stock issued in exchange with Nutranomics	25,005,544
Reverse Acquisition And Recapitalization | Share Exchange Agreement | Nutranomics
Organization And Basis Of Presentation [Line Items]
Number of common stock shares exchanged	8,994,800

ORGANIZATION AND BASIS OF PRE29

ORGANIZATION AND BASIS OF PRESENTATION (Detail Textuals 1) - Nutriband Ltd. ("Nutriband") - shares	1 Months Ended
	Jan. 29, 2015	Jan. 26, 2015
Organization And Basis Of Presentation [Line Items]
Number of common stock issued under acquisition	3,172,554
Share Exchange Agreement
Organization And Basis Of Presentation [Line Items]
Percentage of shares acquired		100.00%
Number of common stock issued under acquisition		3,172,554
Percentage of perpetual royalty on gross global sales		10.00%

SUMMARY OF SIGNIFICANT ACCOUN30

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Detail Textuals) - USD ($)	9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Jul. 31, 2014
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common stock contingently obligated to issue in excess	750,000,000		750,000,000
Percentage of return on sale description	less than 1% of sales	less than 1% of sales
Unearned revenue	$ 315,327		$ 338,263
Convertible notes
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Anti-dilutive shares related to convertible notes	249,636,981

COMMITMENTS, CONTINGENCIES AN31

COMMITMENTS, CONTINGENCIES AND LEGAL MATTERS (Detail Textuals) - USD ($)	1 Months Ended
	Jan. 16, 2015	Mar. 20, 2014
Health Education Corporation ("Health Education")
Commitments Contingencies And Legal Matters [Line Items]
Return of deposit paid by EpicEra Incorporated		$ 100,000
NHK Laboratories, Inc.
Commitments Contingencies And Legal Matters [Line Items]
Principal, interest and attorney fees charged	$ 79,769.92

LEASES (Details)

LEASES (Details)	Jul. 31, 2014USD ($)
Year Ended July 31,
2,015	$ 39,000
2,016	$ 40,500
2,017
2,018
Thereafter
Total lease obligations	$ 79,500

LEASES (Detail Textuals)

LEASES (Detail Textuals)	9 Months Ended		12 Months Ended
	Apr. 30, 2015USD ($)ft²Sublease	Apr. 30, 2014USD ($)	Jul. 31, 2014Sublease
Leases [Line Items]
Area of office (in square foot) | ft²	3,000
Expiry date of lease	December 15, 2014
Renewal term	2 years
Rent expenses	$ 37,475	$ 35,910
Number of subleases room | Sublease	3
Area of subleased property (in square feet) | ft²	1,500
Number of subleases terminated | Sublease			1
Rent received	$ 0	1,850
Machinery and equipment
Leases [Line Items]
Rent expenses	$ 2,648	$ 3,277

RELATED PARTY NOTES PAYABLE (De

RELATED PARTY NOTES PAYABLE (Detail Textuals) - USD ($)	Dec. 12, 2014	Jan. 31, 2012	Apr. 30, 2015	Apr. 30, 2014	Jul. 31, 2014
Debt Instrument [Line Items]
Repayment of note payable in cash			$ 36,608	$ 7,070
Additional paid in capital from related party debt settlement			$ 3,989
Convertible notes payable | Director
Debt Instrument [Line Items]
Maturity period of note payable		2 years
Percentage of interest rate on note payable		0.00%
Percentage of imputed interest rate on note payable		8.00%
Note payable		$ 150,000
Maturity date of note payable		Dec. 31, 2014
Amount of principal in related party notes payable	$ 35,036				$ 36,608
Repayment of note payable in cash	30,000
Additional paid in capital from related party debt settlement	3,989
Offsets amount related party liabilities	$ 1,138

RELATED PARTY PAYABLE (Detail T

RELATED PARTY PAYABLE (Detail Textuals) - USD ($)	9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Jul. 31, 2014
Related Party Transaction [Line Items]
Related party payable	$ 17,239		$ 21,083
Director
Related Party Transaction [Line Items]
Amount lent by director	0	$ 0
Repayment made by company	$ 3,844	$ 9,019

LINES OF CREDIT AND LOAN PAYA36

LINES OF CREDIT AND LOAN PAYABLE (Details) - USD ($)	Apr. 30, 2015	Jul. 31, 2014
Debt Instrument [Line Items]
Total Loan payable	$ 177,616	$ 208,901
Less current portion	35,426	51,071
Loan payable, long-term	142,190	157,830
$250,000 face value, converted from a LOC on August 28, 2013, interest rate of 5.21%, matures on September 1, 2018.
Debt Instrument [Line Items]
Total Loan payable	$ 177,615	$ 208,901

LINES OF CREDIT AND LOAN PAYA37

LINES OF CREDIT AND LOAN PAYABLE (Detail Textuals) - USD ($)	1 Months Ended		9 Months Ended
	Aug. 28, 2012	Jul. 31, 1998	Apr. 30, 2015	Jul. 31, 2014
Line of Credit Facility [Line Items]
Note payable			$ 177,616	$ 208,901
Lines of credit, current			$ 36,234	33,098
Loans Payable
Line of Credit Facility [Line Items]
Line of credit facility, repayment period			5 years
Percentage of interest rate on note payable			5.21%
Debt instrument basis spread on variable rate			1.96%
Face amount of note payable			$ 250,000
Maturity date of note payable			Sep. 1, 2018
Note payable, minimum monthly payments			$ 4,745
Note payable, frequency of minimum monthly payments			monthly
Note payable			$ 177,615	$ 208,901
Loan payable paid in principal repayment			72,385
Note payable, allowable portion to be absorbed			50,000
Note payable, issuance cost			4,037
Extention fee			1,590
Legal fees			$ 1,429
Key Bank | Line of Credit
Line of Credit Facility [Line Items]
Line of credit facility, amount	$ 250,000
Line of credit draw period	1 year
Line of credit, initial interest rate	5.21%
Zions Bank | Line of Credit
Line of Credit Facility [Line Items]
Line of credit facility, amount		$ 40,000
Line of credit, initial interest rate		5.25%

CONVERTIBLE NOTES PAYABLE AND38

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Details) - USD ($)	Apr. 30, 2015	Jul. 31, 2014
Debt Instrument [Line Items]
Convertible notes payable-current portion net of discount	$ 467,560	$ 58,999
Convertible notes payable, long-term	181,426	525,000
Convertible notes payable
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	648,986	583,999
Current Portion of Notes	637,074	174,500
Discount on Notes	169,514	115,501
Convertible notes payable-current portion net of discount	467,560	58,999
Convertible notes payable, long-term	181,426	525,000
Convertible notes payable | Convertible notes payable matures on September 27th, 2015
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	250,000	250,000
Convertible notes payable | Convertible notes payable matures on October 18th, 2015
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	125,000	125,000
Convertible notes payable | Convertible notes payable matures on November 22nd, 2015
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	$ 150,000	150,000
Convertible notes payable | Convertible notes payable matures on October 14th, 2014
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties		29,759
Convertible notes payable | Convertible notes payable matures on December 26th, 2014
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties		13,913
Convertible notes payable | Convertible notes payable matures on February 2nd, 2015
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	$ 63,000	$ 15,327
Convertible notes payable | Convertible notes payable matures on December 2nd, 2015
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	30,004
Convertible notes payable | Convertible notes payable matures on September 2nd, 2016
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	13,736
Convertible notes payable | Convertible notes payable matures on December 16th, 2016
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	12,004
Convertible notes payable | Convertible notes payable matures on December 19th, 2015
Debt Instrument [Line Items]
Total convertible notes payable - non-related parties	$ 5,242

CONVERTIBLE NOTES PAYABLE AND39

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Detail Textuals) - Convertible notes payable - Unrelated party	9 Months Ended
	Apr. 30, 2015USD ($)Day$ / shares	Jul. 31, 2014USD ($)
Convertible notes payable matures on September 27th, 2015
Debt Instrument [Line Items]
Note payable	$ 250,000
Maturity date of convertible note	Sep. 27, 2015
Interest rate of convertible note	10.00%
Floor price of convertible note | $ / shares	$ 0.005
Number of threshold trading days | Day	5
Convertible notes payable matures on October 18th, 2015
Debt Instrument [Line Items]
Note payable	$ 125,000
Maturity date of convertible note	Oct. 18, 2015
Interest rate of convertible note	10.00%
Floor price of convertible note | $ / shares	$ 0.005
Number of threshold trading days | Day	5
Convertible notes payable matures on November 22nd, 2015
Debt Instrument [Line Items]
Note payable	$ 150,000
Maturity date of convertible note	Nov. 22, 2015
Interest rate of convertible note	10.00%
Floor price of convertible note | $ / shares	$ 0.005
Number of threshold trading days | Day	5
Convertible notes payable matures on October 14th, 2014
Debt Instrument [Line Items]
Note payable	$ 78,500
Maturity date of convertible note	Oct. 14, 2014
Interest rate of convertible note	8.00%
Default rate of convertible note	22.00%
Floor price of convertible note | $ / shares	$ 0.00005
Unamortized discount	$ 29,759	$ 78,500
Number of threshold trading days | Day	10
Convertible notes payable matures on December 26th, 2014
Debt Instrument [Line Items]
Note payable	$ 53,000
Maturity date of convertible note	Dec. 26, 2014
Interest rate of convertible note	8.00%
Default rate of convertible note	22.00%
Floor price of convertible note | $ / shares	$ 0.00005
Unamortized discount	$ 13,913	33,000
Number of threshold trading days | Day	3
Convertible notes payable matures on February 2nd, 2015
Debt Instrument [Line Items]
Note payable	$ 63,000
Maturity date of convertible note	Feb. 2, 2015
Interest rate of convertible note	8.00%
Default rate of convertible note	22.00%
Floor price of convertible note | $ / shares	$ 0.00005
Unamortized discount	$ 0	47,673
Number of threshold trading days | Day	3
Convertible notes payable matures on December 2nd, 2015
Debt Instrument [Line Items]
Note payable	$ 73,500
Maturity date of convertible note	Dec. 2, 2015
Interest rate of convertible note	8.00%
Unamortized discount	$ 43,496	0
Number of threshold trading days | Day	10
Convertible notes payable matures on September 2nd, 2016
Debt Instrument [Line Items]
Note payable	$ 59,000
Maturity date of convertible note	Sep. 2, 2016
Interest rate of convertible note	8.00%
Unamortized discount	$ 45,264	0
Convertible notes payable matures on December 16th, 2016
Debt Instrument [Line Items]
Note payable	$ 65,000
Maturity date of convertible note	Dec. 16, 2016
Interest rate of convertible note	0.00%
Unamortized discount	$ 52,996	0
Convertible notes payable matures on December 19th, 2015
Debt Instrument [Line Items]
Note payable	$ 33,000
Maturity date of convertible note	Dec. 19, 2015
Interest rate of convertible note	8.00%
Floor price of convertible note | $ / shares	$ 0.00005
Unamortized discount	$ 27,758	$ 0
Number of threshold trading days | Day	3

CONVERTIBLE NOTES PAYABLE AND40

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Detail Textuals 1) - USD ($)	Mar. 04, 2015	Feb. 09, 2015	Dec. 12, 2014	Dec. 08, 2014	Nov. 14, 2014	Oct. 09, 2014	Oct. 02, 2014	May. 15, 2014	Jan. 14, 2014	Mar. 23, 2015	Jan. 26, 2015	Jan. 20, 2015	Dec. 23, 2014	Sep. 24, 2014	Mar. 19, 2014	Apr. 30, 2015	Jul. 31, 2014
Debt Instrument [Line Items]
Debt convertible, beneficial conversion feature																$ (172,582)
Convertible note shares																19,014,177
Convertible notes payable
Debt Instrument [Line Items]
Remaining principal amount																$ 648,986	$ 583,999
Convertible notes payable | Asher Enterprises, Inc. ("Asher")
Debt Instrument [Line Items]
Percentage of common stock price to conversion price									58.00%
Principal payments made during the period									$ 58,600
Legal and accounting fees									19,900
Debt convertible, beneficial conversion feature									87,968
Unamortized discount									78,500
Debt conversion amount			$ 12,500	$ 12,500	$ 15,000	$ 12,000	$ 15,000		$ 78,500				$ 12,500	$ 15,000
Convertible note shares			1,041,667	1,041,667	931,677	869,565	810,811						1,686,111	583,658
Common stock convertible conversion per share			$ 0.012	$ 0.012	$ 0.0161	$ 0.0138	$ 0.0185						$ 0.0072	$ 0.0257
Remaining principal amount				$ 9,000	$ 21,500	$ 36,500							$ 0			0
Convertible notes payable | KBM Worldwide, Inc. ("KBM")
Debt Instrument [Line Items]
Number of days unpaid accrued interest								180 days							180 days
Percentage of common stock price to conversion price								58.00%							58.00%
Principal payments made during the period								$ 42,500							$ 24,487
Legal and accounting fees								17,500							6,898
Debt convertible, beneficial conversion feature								56,591							47,806
Unamortized discount								$ 56,591							49,010
Debt conversion amount	$ 9,055	$ 11,455								$ 12,490	$ 15,000	$ 5,000			$ 20,000
Accrued interest										$ 2,120
Convertible note shares	2,382,895	2,793,902								4,427,273	2,586,207	892,857
Common stock convertible conversion per share	$ 0.0038	$ 0.0041								$ 0.0056	$ 0.0058	$ 0.0056
Remaining principal amount	$ 12,490	$ 21,545								$ 0	$ 33,000	$ 48,000				$ 0

CONVERTIBLE NOTES PAYABLE AND41

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Detail Textuals 2) - USD ($)	Dec. 01, 2014	Apr. 30, 2015	Apr. 30, 2014	Dec. 02, 2014
Debt Instrument [Line Items]
Cash received from convertible note		$ 363,048	$ 656,500
Convertible notes payable | LG Capital Funding, LLC | 8% Convertible Promissory Note
Debt Instrument [Line Items]
Number of days unpaid accrued interest	180 days
Conversion price average of the lowest three closing bid prices	58.00%
Cash received from convertible note	$ 70,000
Legal and other origination expenses	$ 3,500
Additional convertible note due on August 2, 2015				$ 73,500

CONVERTIBLE NOTES PAYABLE AND42

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Detail Textuals 3)	Dec. 10, 2014USD ($)	Dec. 01, 2014USD ($)TrancheNoteshares	Apr. 30, 2015USD ($)	Dec. 02, 2014USD ($)$ / shares
Debt Instrument [Line Items]
Debt convertible, beneficial conversion feature			$ (172,582)
10% convertible promissory note | Typenex Co-Investment, LLC ("Typenex")
Debt Instrument [Line Items]
Interest rate of convertible note				10.00%
Principal amount of convertible note				$ 224,000
Amount of original interest discount	$ 59,000			20,000
Legal fees and other expenses		$ 4,000
Amount of initial tranche		59,000
Amount received from initial tranche	50,000	50,000
Initial amount of tranche utilized for legal and other expenses		4,000
Original interest discount included in discount		$ 5,000
Conversion price average of the lowest three closing bid prices		58.00%
Trading days		10 days
Number of remaining tranches | Tranche		3
Amount of principal and original interest discount				55,000
Principal amount of remaining tranche in original interest discount				50,000
Interest amount of remaining tranche in original interest discount				$ 5,000
Face amount of newly issued promissory notes		$ 50,000
Number of promissory notes issued | Note		3
Number of warrants issued (in shares) | shares		4
Value of shares issued for warrants		$ 112,000
Amount of warrants initially issued		29,500
Amount of warrants issued thereafter		$ 27,500
Exercise price of warrants (in dollars per share) | $ / shares				$ 0.06
Debt convertible, beneficial conversion feature	$ 84,512

CONVERTIBLE NOTES PAYABLE AND43

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Detail Textuals 4) - USD ($)	Dec. 01, 2014	Dec. 16, 2014	Apr. 30, 2015	Dec. 02, 2014
Debt Instrument [Line Items]
Debt convertible, beneficial conversion feature			$ (172,582)
Convertible notes payable | JMJ Financial
Debt Instrument [Line Items]
Principal amount of convertible note				$ 350,000
Amount of original interest discount		$ 65,000		$ 35,000
Amount of initial tranche	$ 55,000
Conversion price average of the lowest three closing bid prices	65.00%
Trading days	25 days
Debt convertible, beneficial conversion feature		$ 71,321

CONVERTIBLE NOTES PAYABLE AND44

CONVERTIBLE NOTES PAYABLE AND LOAN PAYABLE (Detail Textuals 5) - USD ($)	May. 15, 2014	Jan. 14, 2014	Mar. 17, 2015	Mar. 19, 2014	Apr. 30, 2015	Apr. 30, 2014	Mar. 23, 2015	Mar. 04, 2015	Feb. 09, 2015	Jan. 26, 2015	Jan. 20, 2015	Dec. 23, 2014	Dec. 12, 2014	Dec. 08, 2014	Nov. 14, 2014	Oct. 09, 2014	Oct. 02, 2014	Sep. 24, 2014	Jul. 31, 2014
Debt Instrument [Line Items]
Debt convertible, beneficial conversion feature					$ (172,582)
Fair value of financial instrument classified as derivative asset (liability)					188,391														$ 177,907
Change in fair value of derivative liability					49,878	$ 49,878
Amortization of debt discount					156,939	13,643
Amortization of interest expenses on conversion					$ 9,602	$ 0
Convertible notes payable | Asher Enterprises, Inc. ("Asher")
Debt Instrument [Line Items]
Percentage of common stock price to conversion price		58.00%
Legal and accounting fees		$ 19,900
Debt convertible, beneficial conversion feature		87,968
Unamortized discount		78,500
Conversion price per share												$ 0.0072	$ 0.012	$ 0.012	$ 0.0161	$ 0.0138	$ 0.0185	$ 0.0257
Principal payments made during the period		$ 58,600
Convertible notes payable | KBM Worldwide, Inc. ("KBM")
Debt Instrument [Line Items]
Number of days unpaid accrued interest	180 days			180 days
Percentage of common stock price to conversion price	58.00%			58.00%
Legal and accounting fees	$ 17,500			$ 6,898
Debt convertible, beneficial conversion feature	56,591			47,806
Unamortized discount	56,591			49,010
Conversion price per share							$ 0.0056	$ 0.0038	$ 0.0041	$ 0.0058	$ 0.0056
Principal payments made during the period	$ 42,500			$ 24,487
Convertible notes payable | Vis Vires Group
Debt Instrument [Line Items]
Number of days unpaid accrued interest			180 days
Percentage of common stock price to conversion price			58.00%
Legal and accounting fees			$ 13,000
Debt convertible, beneficial conversion feature			35,444
Unamortized discount			33,000
Principal payments made during the period			$ 20,000

STOCK TRANSACTIONS (Detail Text

STOCK TRANSACTIONS (Detail Textuals) - $ / shares	Apr. 30, 2015	Jul. 31, 2014
Stockholders' Equity Note [Abstract]
Common stock, shares authorized	750,000,000	750,000,000
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, shares issued	161,481,887	51,151,766
Common stock, shares outstanding	161,481,887	51,151,766

STOCK TRANSACTIONS (Detail Te46

STOCK TRANSACTIONS (Detail Textuals 1) - USD ($)	Mar. 04, 2015	Feb. 09, 2015	Dec. 12, 2014	Dec. 08, 2014	Nov. 14, 2014	Oct. 09, 2014	Oct. 02, 2014	Jan. 14, 2014	Mar. 23, 2015	Jan. 26, 2015	Jan. 20, 2015	Dec. 23, 2014	Sep. 24, 2014	Mar. 19, 2014	Apr. 30, 2015	Jul. 31, 2014	May. 15, 2014
Stock Transactions [Line Items]
Common stock shares issued related to convertible notes															19,014,177
Common stock issued for share-based compensation, acquisitions, and consulting services															90,715,944
Convertible notes payable
Stock Transactions [Line Items]
Remaining principal amount															$ 648,986	$ 583,999
Asher Enterprises, Inc. ("Asher") | Convertible notes payable
Stock Transactions [Line Items]
Debt conversion amount			$ 12,500	$ 12,500	$ 15,000	$ 12,000	$ 15,000	$ 78,500				$ 12,500	$ 15,000
Conversion price per share			$ 0.012	$ 0.012	$ 0.0161	$ 0.0138	$ 0.0185					$ 0.0072	$ 0.0257
Common stock shares issued related to convertible notes			1,041,667	1,041,667	931,677	869,565	810,811					1,686,111	583,658
Remaining principal amount				$ 9,000	$ 21,500	$ 36,500						$ 0			0
Asher Enterprises, Inc. ("Asher") | Fourth conversion | Convertible notes payable
Stock Transactions [Line Items]
Debt conversion amount					$ 15,000
Conversion price per share					$ 0.0521
Accrued interest					$ 931,677
Asher Enterprises, Inc. ("Asher") | Sixth conversion | Convertible notes payable
Stock Transactions [Line Items]
Debt conversion amount												$ 9,000
Conversion price per share												$ 0.0072
Common stock shares issued related to convertible notes												1,686,111
Accrued interest												$ 3,140
KBM Worldwide, Inc. ("KBM") | Convertible notes payable
Stock Transactions [Line Items]
Face amount of note payable														$ 53,000			$ 63,000
Debt conversion amount	$ 9,055	$ 11,455							$ 12,490	$ 15,000	$ 5,000			$ 20,000
Conversion price per share	$ 0.0038	$ 0.0041							$ 0.0056	$ 0.0058	$ 0.0056
Common stock shares issued related to convertible notes	2,382,895	2,793,902							4,427,273	2,586,207	892,857
Accrued interest									$ 2,120
Remaining principal amount	$ 12,490	$ 21,545							0	$ 33,000	$ 48,000				$ 0
KBM Worldwide, Inc. ("KBM") | Fifth conversion | Convertible notes payable
Stock Transactions [Line Items]
Debt conversion amount									$ 12,490
Conversion price per share									$ 0.0033
Common stock shares issued related to convertible notes									4,427,273
Accrued interest									$ 2,120
Remaining principal amount									$ 0
Equity Purchase Agreement
Stock Transactions [Line Items]
Number of common stock issued under agreement for cash															600,000
Value of common stock issued under agreement															$ 37,990

STOCK TRANSACTIONS (Detail Te47

STOCK TRANSACTIONS (Detail Textuals 2)	1 Months Ended
	Jan. 29, 2015shares
Stock Transactions [Line Items]
Common stock issued to outside consultant for consulting services	5,768,280
Michael Doron | Consideration for previous appointment to Board of Directors
Stock Transactions [Line Items]
Common stock shares issued as share-based compensation	5,000,000
Michael Doron | Consideration for negotiation and closing of the Nutriband acquisition
Stock Transactions [Line Items]
Common stock shares issued as share-based compensation	2,500,000
Michael Doron | Consideration for employment contract
Stock Transactions [Line Items]
Common stock shares issued as share-based compensation	30,157,463
Nutriband Ltd. ("Nutriband")
Stock Transactions [Line Items]
Number of common stock issued under acquisition	3,172,554
AES intellectual property
Stock Transactions [Line Items]
Number of common stock issued under acquisition	44,117,647

STOCK TRANSACTIONS (Detail Te48

STOCK TRANSACTIONS (Detail Textuals 3)	Dec. 09, 2013USD ($)Day	Apr. 30, 2015USD ($)shares
Stock Transactions [Line Items]
Cash received from Issuance shares		$ 37,990
Equity Purchase Agreement
Stock Transactions [Line Items]
Number of common stock issued under agreement for cash | shares		600,000
Equity Purchase Agreement | Southridge Partners II, LP ("Southridge")
Stock Transactions [Line Items]
Maximum issued amount of common stock	$ 10,000,000
Term of agreement	24 months
Minimum percentage of common stock sold	90.00%
Number of daily volume weighted average prices | Day	3
Number of trading days	10 days
Put notice description	The Company will deliver to Southridge, simultaneously with delivery of a Put Notice, a number of Shares equal to 125% of the Investment Amount divided by the closing price of the Company's common stock on the day preceding the Put Notice date (the "Estimated Put Shares").
Equity purchase agreement, condition	(i) 24 months from the effective date of a registration statement to be filed in connection therewith or (ii) the date on which Southridge has purchased shares of common stock pursuant to this agreement for an aggregate maximum purchase price of $10,000,000; such commitment is subject to certain conditions. The purchase price to be paid by Southridge will be 90% of the average of the lowest three (3) daily volume weighted average prices for the Company's common stock for the ten (10) trading days immediately following clearing of the Estimated Put Shares (defined below) (such purchase price the "Put Purchase Price") under the Equity Purchase Agreement.
Number of common stock issued under agreement for cash | shares		2,107,554
Cash received from Issuance shares		$ 137,120
Equity Purchase Agreement | Southridge Partners II, LP ("Southridge") | Promissory Note
Stock Transactions [Line Items]
Minimum percentage of common stock sold	9.99%
Principal amount of convertible note	$ 50,000
Interest paid on agreement	0.00%
Maturity date of note payable	May 31, 2014

DERIVATIVE LIABILITY (Details)

DERIVATIVE LIABILITY (Details)	9 Months Ended
	Apr. 30, 2015USD ($)
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at July 31, 2014	$ 177,907
Conversions	(172,582)
Total (gains) losses included in earnings	(49,878)
Issuances	232,944
Balance at April 30, 2015	$ 188,391

DERIVATIVE LIABILITY (Detail 1)

DERIVATIVE LIABILITY (Detail 1) - 9 months ended Apr. 30, 2015	Total
Derivatives, Fair Value [Line Items]
Dividend yield	0.00%
Minimum
Derivatives, Fair Value [Line Items]
Expected term in years
Risk-free interest rates	0.01%
Volatility	194.00%
Maximum
Derivatives, Fair Value [Line Items]
Expected term in years	3 months 4 days
Risk-free interest rates	0.28%
Volatility	202.00%

DERIVATIVE LIABILITY (Detail Te

DERIVATIVE LIABILITY (Detail Textuals)	Apr. 30, 2015USD ($)
Derivative Liability [Abstract]
Fair value of financial instrument classified as derivative asset (liability)	$ 188,391

INDUSTRY SEGMENT, GEOGRAPHIC 52

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Details) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014
Segment Reporting Information [Line Items]
Revenue	$ 432,414	$ 716,763	$ 1,345,110	$ 1,943,742
Revenue
Segment Reporting Information [Line Items]
Revenue	$ 432,414	$ 716,763	$ 1,345,110	$ 1,943,742
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Americas | Revenue
Segment Reporting Information [Line Items]
Revenue	$ 211,066	$ 441,739	$ 718,860	$ 1,425,517
Concentration risk, percentage	48.81%	61.63%	53.44%	73.34%
North Asia | Revenue
Segment Reporting Information [Line Items]
Revenue	$ 2,135	$ 6,623	$ 13,973	$ 33,417
Concentration risk, percentage	0.49%	0.92%	1.04%	1.72%
Greater China | Revenue
Segment Reporting Information [Line Items]
Revenue	$ 40,976	$ 73,603	$ 211,523	$ 114,690
Concentration risk, percentage	9.48%	10.27%	15.73%	5.90%
Middle East | Revenue
Segment Reporting Information [Line Items]
Revenue			$ 46
Concentration risk, percentage
South Asia/Pacific | Revenue
Segment Reporting Information [Line Items]
Revenue	$ 176,036	$ 189,798	$ 397,338	$ 365,118
Concentration risk, percentage	40.71%	26.48%	29.54%	18.78%
Europe | Revenue
Segment Reporting Information [Line Items]
Revenue	$ 2,201	$ 5,000	$ 3,370	$ 5,000
Concentration risk, percentage	0.51%	0.70%	0.25%	26.00%

INDUSTRY SEGMENT, GEOGRAPHIC 53

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Details 1) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014	Jul. 31, 2014
Segment Reporting Information [Line Items]
Equipment	$ 10,583		$ 10,583		$ 16,355
Equipment
Segment Reporting Information [Line Items]
Equipment	$ 10,583	$ 16,355	$ 10,583	$ 16,355
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Americas | Equipment
Segment Reporting Information [Line Items]
Equipment	$ 10,583	$ 16,355	$ 10,583	$ 16,355
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
North Asia | Equipment
Segment Reporting Information [Line Items]
Equipment
Concentration risk, percentage
Greater China | Equipment
Segment Reporting Information [Line Items]
Equipment
Concentration risk, percentage
South Asia/Pacific | Equipment
Segment Reporting Information [Line Items]
Equipment
Concentration risk, percentage
Europe | Equipment
Segment Reporting Information [Line Items]
Equipment
Concentration risk, percentage

INDUSTRY SEGMENT, GEOGRAPHIC 54

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Details 2) - USD ($)	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014
Segment Reporting Information [Line Items]
Revenue	$ 432,414	$ 716,763	$ 1,345,110	$ 1,943,742
Revenue
Segment Reporting Information [Line Items]
Revenue	$ 432,414	$ 716,763	$ 1,345,110	$ 1,943,742
Concentration risk, percentage	100.00%	100.00%	100.00%	100.00%
Product Sales | Revenue
Segment Reporting Information [Line Items]
Revenue	$ 431,893	$ 713,438	$ 1,337,130	$ 1,929,028
Concentration risk, percentage	99.88%	99.54%	99.41%	99.24%
NBA Services | Revenue
Segment Reporting Information [Line Items]
Revenue	$ 521	$ 3,325	$ 7,980	$ 14,714
Concentration risk, percentage	0.12%	0.46%	0.59%	0.76%
Educational Services | Revenue
Segment Reporting Information [Line Items]
Revenue
Concentration risk, percentage

INDUSTRY SEGMENT, GEOGRAPHIC 55

INDUSTRY SEGMENT, GEOGRAPHIC INFORMATION AND SIGNIFICANT CUSTOMERS (Detail Textuals) - Customer	3 Months Ended		9 Months Ended
	Apr. 30, 2015	Apr. 30, 2014	Apr. 30, 2015	Apr. 30, 2014
Segment Reporting Information [Line Items]
Number of geographic regions			6
Revenue
Segment Reporting Information [Line Items]
Percentage of total sales by customer	100.00%	100.00%	100.00%	100.00%
Revenue | Customer Concentration Risk
Segment Reporting Information [Line Items]
Number of customers	3	3	3	3
Percentage of total sales by customer	36.70%	37.20%	32.60%	46.10%

SUBSEQUENT EVENTS (Detail Textu

SUBSEQUENT EVENTS (Detail Textuals) - USD ($)	May. 12, 2015	Mar. 04, 2015	Feb. 09, 2015	Mar. 23, 2015	Jan. 26, 2015	Jan. 20, 2015	Mar. 19, 2014	Apr. 30, 2015	Jul. 31, 2014
Subsequent Event [Line Items]
Common stock shares issued related to convertible notes								19,014,177
Convertible notes payable
Subsequent Event [Line Items]
Remaining principal amount								$ 648,986	$ 583,999
KBM Worldwide, Inc. ("KBM") | Convertible notes payable
Subsequent Event [Line Items]
Amount of convertible note for conversion		$ 9,055	$ 11,455	$ 12,490	$ 15,000	$ 5,000	$ 20,000
Common stock shares issued related to convertible notes		2,382,895	2,793,902	4,427,273	2,586,207	892,857
Conversion price per share		$ 0.0038	$ 0.0041	$ 0.0056	$ 0.0058	$ 0.0056
Remaining principal amount		$ 12,490	$ 21,545	$ 0	$ 33,000	$ 48,000		$ 0
Subsequent Event | KBM Worldwide, Inc. ("KBM") | Convertible notes payable
Subsequent Event [Line Items]
Amount of convertible note for conversion	$ 12,890
Common stock shares issued related to convertible notes	8,056,250
Conversion price per share	$ 0.0016
Remaining principal amount	$ 50,110